1 condition in the Repatriation Medical Authority's Statements of Principles list aplastic anaemia as a factor. If DVA has accepted your aplastic anaemia, each of these has a documented pathway to a further claim.
Some Statement of Principles factors are not about service at all — they name another condition. Where DVA has already accepted your aplastic anaemia, and another condition's SoP lists aplastic anaemia as a factor, that part of the next claim is already established on your file. How a secondary claim works, in full →
Quoted from the instrument. A pathway existing is not the same as a claim succeeding — each factor carries thresholds your record has to satisfy.
RH No. 21 of 2024 · BoP No. 22 of 2024
Reasonable Hypothesis — factor (2): “having one of the following haematological disorders at the time of clinical onset: (a) myelodysplastic syndrome; (b) myelodysplastic/myeloproliferative neoplasm; (c) aplastic anaemia; or (d) paroxysmal nocturnal haemoglobinuria” [clinical onset]
Balance of Probabilities — factor (2): “having one of the following haematological disorders at the time of clinical onset: (a) myelodysplastic syndrome; (b) myelodysplastic/myeloproliferative neoplasm; (c) aplastic anaemia; or (d) paroxysmal nocturnal haemoglobinuria” [clinical onset]
Note: myelodysplastic / myeloproliferative neoplasm is defined in the Schedule 1 - Dictionary.
If any of these is also on your file, it reaches some of the same conditions aplastic anaemia does.
A claim is tested against the definition first. If the diagnosis on your file does not meet this wording, the factors below never get reached — so it is worth checking that what your doctor wrote matches what the instrument requires.
Aplastic anaemia, for the purposes of the Statement of Principles, for the purposes of this Statement of Principles, aplastic anaemia: (a) means bone marrow failure, characterised by: (i) destruction of haematopoietic stem cells with peripheral blood cytopaenia; and (ii) hypocellular bone marrow in which normal haematopoietic tissue is replaced by fatty marrow; and (b) excludes: (i) inherited bone marrow failure syndromes, including Fanconi anaemia, dyskeratosis congenita, Shwachman- Diamond syndrome and inherited amegakaryocytic thrombocytopaenia; (ii) isolated leukopaenia and isolated thrombocytopaenia; (iii) myelodysplastic syndrome; (iv) paroxysmal nocturnal haemoglobinuria; and (v) replacement of bone marrow due to fibrosis or an infiltrative neoplastic process. (3) While aplastic anaemia attracts ICD-10-AM code D61.1, D61.2, D61.3 or D61.8, in applying this Statement of Principles the meaning of aplastic anaemia is that given in subsection (2). (4) For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective
Aggravation-only factors. In this instrument, subsections 9(14) apply only to material contribution to, or aggravation of, aplastic anaemia where it was already present before or during service. If service caused aplastic anaemia outright, those factors are not available to you.
RH No. 58 of 2020 · BoP No. 59 of 2020 · 12 factors
The Statement of Principles for aplastic anaemia names 1 other condition among its own factors. If any of these is already accepted on your file, it may be the factor that carries a aplastic anaemia claim — quoted here from the instrument.
Reasonable Hypothesis — factor (13): “having an infection with parvovirus B19 or acute infectious mononucleosis within the six months before the clinical onset of aplastic anaemia” [clinical onset]

Reviewed by Dr Thomas Perkins
Founding doctor, Veterans Health Centre · former RAAF aviation medical officer · 13 years working exclusively with ADF members and veterans. Full profile →
Contact us for more information.